Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy (Q46769754)

25 December 2017

title

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy (English)

1 reference

25 December 2017

author

Keith Matthews

4

1 reference

25 December 2017

Gillian Smith

object named as

G Smith

2

0 references

C Wolf

object named as

C R Wolf

8

0 references

author name string

M J V Wilkie

1

1 reference

25 December 2017

R K Day

3

1 reference

25 December 2017

D Smith

5

1 reference

25 December 2017

D Blackwood

6

1 reference

25 December 2017

I C Reid

7

1 reference

25 December 2017

publication date

5 February 2008

1 reference

25 December 2017

The Pharmacogenomics Journal

published in

1 reference

25 December 2017

volume

9

1 reference

25 December 2017

page(s)

61-70

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500491

exact match

0 references

cites work

Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Investigation of serotonin-related genes in antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Synaptic plasticity and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

A public health approach to pharmacogenomics and gene-based diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Genetic diversity of the human serotonin receptor 1B (HTR1B) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

Organization of the human serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

How common is resistance to treatment in recurrent, nonpsychotic geriatric depression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Increased serotonin-2 binding sites in frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

1 reference

7 January 2021

Serotonin-6 receptor variant (C267T) and clinical response to clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500491

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500491

1 reference

25 December 2017

PubMed ID

18253134

1 reference

25 December 2017